Suppr超能文献

PDGFRB基因的新型突变导致中国家族性原发性脑钙化。

Novel mutations of PDGFRB cause primary familial brain calcification in Chinese families.

作者信息

Wang Chong, Yao Xiang-Ping, Chen Hai-Ting, Lai Jing-Hui, Guo Xin-Xin, Su Hui-Zhen, Dong En-Lin, Zhang Qi-Jie, Wang Ning, Chen Wan-Jin

机构信息

Department of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Fujian Key Laboratory of Molecular Neurology, Fuzhou, China.

出版信息

J Hum Genet. 2017 Jul;62(7):697-701. doi: 10.1038/jhg.2017.25. Epub 2017 Mar 16.

Abstract

Four causative genes, including solute carrier family 20 member 2 (SLC20A2), platelet-derived growth factor receptor b (PDGFRB), platelet-derived growth factor b (PDGFB)and xenotropic and polytropic retrovirus receptor 1 (XPR1), have been identified to cause primary familial brain calcification (PFBC). However, PDGFRB mutations seem to be quite rare and no PDGFRB mutations have been reported in Chinese PFBC patients. A total of 146 PFBC patients including 12 families and 134 sporadic patients were recruited in this study. All of them were previously tested negative for the SLC20A2. Mutational analyses of the entire exons and exon-intron boundaries of PDGFRB were carried out by direct gene sequencing. In silico analyses of the identified variants were conducted using Mutation Taster, PolyPhen-2 and Sorts Intolerant From Tolerant. Two heterozygous variants, c.3G>A and c.2209G>A, of the PDGFRB gene were revealed in two PFBC families, respectively. These two variants were not observed in 200 healthy controls. The variant c.3G>A was located in exon 2 and affected the initiation codon of the PDGFRB gene. The variant c.2209G>A resulted in amino-acid substitutions of aspartic acid to asparagine at position 737. Both of these two variants co-segregated with the disease phenotype (variant carriers in Family 1: I1, II2 and II3; variant carriers in Family 2: I2 and II8), suggesting a pathogenic impact of these variants. The prevalence of PDGFRB mutations in Chinese PFBC patients seems to be quite low, indicating that PDGFRB is not a major causative gene of PFBC in Chinese population.

摘要

包括溶质载体家族20成员2(SLC20A2)、血小板衍生生长因子受体b(PDGFRB)、血小板衍生生长因子b(PDGFB)和嗜异性及多嗜性逆转录病毒受体1(XPR1)在内的4个致病基因已被确定可导致原发性家族性脑钙化(PFBC)。然而,PDGFRB突变似乎非常罕见,且中国PFBC患者中尚未有PDGFRB突变的报道。本研究共招募了146例PFBC患者,包括12个家族性患者和134例散发性患者。他们之前均被检测出SLC20A2为阴性。通过直接基因测序对PDGFRB的全部外显子和外显子-内含子边界进行突变分析。使用Mutation Taster、PolyPhen-2和Sorts Intolerant From Tolerant对鉴定出的变异进行计算机分析。在两个PFBC家族中分别发现了PDGFRB基因的两个杂合变异,即c.3G>A和c.2209G>A。在200名健康对照中未观察到这两个变异。变异c.3G>A位于外显子2,影响PDGFRB基因的起始密码子。变异c.2209G>A导致第737位氨基酸由天冬氨酸替换为天冬酰胺。这两个变异均与疾病表型共分离(家族1中的变异携带者:I1、II2和II3;家族2中的变异携带者:I2和II8),表明这些变异具有致病作用。中国PFBC患者中PDGFRB突变的发生率似乎相当低,这表明PDGFRB不是中国人群中PFBC的主要致病基因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验